Showing results (1-10 of 509) with videos related to
Sort By:
Pageof 51
Arthritis Research & Therapy|August 11, 2006
Interleukin-6: a new therapeutic targetJosef S Smolen, Ravinder N MainiJoint Bone Spine|February 23, 2002
Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studiesMarc Feldmann, Ravinder N MainiArthritis Research|July 12, 2002
How does infliximab work in rheumatoid arthritis?Ravinder N Maini, Marc FeldmannJournal of Immunology (Baltimore, Md. : 1950)|July 6, 2010
Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us?Marc Feldmann, Ravinder N MainiEuropean Journal of Pharmacology|October 22, 2009
Ten years of infliximab: insights from clinical trials in rheumatoid arthritisJosef S SmolenJournal of Autoimmunity|March 8, 2020
Insights into the treatment of rheumatoid arthritis: A paradigm in medicineJosef S SmolenRheumatic Diseases Clinics of North America|October 1, 2019
Treat to Target in Rheumatology: A Historical Account on Occasion of the 10th AnniversaryJosef S SmolenThe Journal of Rheumatology. Supplement|July 6, 2007
What is the place of recently approved T cell-targeted and B cell-targeted therapies in the treatment of rheumatoid arthritis? Lessons from global clinical trialsJosef S SmolenClinical and Experimental Rheumatology|October 18, 2012
Treat-to-target: rationale and strategiesJosef S SmolenCurrent Opinion in Rheumatology|March 31, 2016
Treat-to-target as an approach in inflammatory arthritisJosef S SmolenPageof 51